GlassScriptPhysician profile
Jose Luis Suarez
NPI 1497757728
$1,641.66
in general payments reported to CMS, 2019-2025
21 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $388 · 2023: $344 · 2024: $358 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.87 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $530.69 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $141.45 | 2021-2025 | Zepbound, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.65 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $131.93 | 2023-2025 | Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $98.26 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbott Laboratories | $94.68 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $81.02 | 2022-2023 | Otezla, Repatha |
| Astellas Pharma US INC | $74.99 | 2024 | |
| Gilead Sciences, INC. | $53.51 | 2025 | |
| Genentech USA, INC. | $46.91 | 2021-2022 | |
| Abbvie INC. | $40.94 | 2023-2024 | |
| Phadia US INC. | $35.35 | 2024 | Immunocap |
| Glaxosmithkline, LLC. | $31.04 | 2023-2024 | Arexvy, Shingrix |
| Medline Industries LP | $25.50 | 2022-2025 | |
| Exact Sciences Corporation | $19.92 | 2025 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.59 | 2022 | |
| Edwards Lifesciences Corporation | $18.46 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Hologic Sales and Service, LLC | $18.39 | 2025 | Aptima |
| Sanofi Pasteur INC. | $15.85 | 2022 | |
| Pfizer INC. | $12.88 | 2023 | |
| Horizon Therapeutics Plc | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.